Danke Weekly Report 20180603: National Telemedicine Center Launched and National Healthcare Security Administration Officially Established
Works | The Sick Child
Author |Gabriel Metsu
Medical History in Pictures | Issue 20180603
Gabriel Metsu was a master artist of the 17th-century Dutch Golden Age. During that period, the Holy Family served as an ideal model, giving rise to various secularized versions of Madonna-themed subjects. The tenderness shown by the mother toward her child in this painting is a profoundly moving reflection of the Madonna and Child motif.
VCBeat aims to categorize the types of capital involved in healthcare services, examining their areas of entry, modes of investment, and latest trends. By integrating factors such as policy, industry dynamics, and corporate motivations, it provides a comprehensive analysis of the phenomenon of capital participation in healthcare services.
Listed companies serve as the optimal window for observing industry dynamics. With the completion of their annual report disclosures, high-value case studies and data support are now available for analyzing industry operational trends. VCBeat has compiled the 2017 annual reports of listed companies in the pharmaceutical commerce sector, aiming to analyze the current competitive landscape and future development trends of the pharmaceutical distribution industry based on these annual report data.
With the rapid growth in sales of pharmaceuticals and medical devices, the role of supply chain cloud platforms will become increasingly important.
How Did CStone Pharmaceuticals Rise to Become a Unicorn in China’s Pharmaceutical Innovation Industry in Just Two Years? VCBeat Interviewed the Founding Team of CStone Pharmaceuticals to Hear Their Story.
In the current market, what pain points does the nursing care industry face? Which companies are entering this sector to provide services, and where do industrial opportunities lie? VCBeat seeks to answer these questions while analyzing the current state of the industry.
Despite the closed nature of the surgical robotics market, its lucrative profit margins have spurred intense interest among numerous players. VCBeat has compiled an overview of emerging companies in the surgical robotics sector, along with their product developments and financing activities in recent years.
On the morning of May 26, the Daxingshan Temple Campus of the First Affiliated Hospital of Xi’an Jiaotong University officially opened for clinical services, markingChina’s First New Medical Model Integrating “Buddhism” and “Medicine”Officially launched in Xi'an.
Keywords: Primary Healthcare, Xi'an
On May 26, the Gansu Wuwei Heavy Ion Therapy Center held the launch ceremony for the clinical trial of its heavy ion therapy system, markingChina's FirstHeavy-ion therapy system with independent intellectual property rights takes a key step toward registration, market launch, and industrialization.
Keywords: Critical Care Treatment, Gansu
On May 27, Poly Pharma announced that it had received the "Drug Supplemental Application Approval" (Approval No. 2018B02894) issued by the China Food and Drug Administration, confirming that its "Azithromycin for Injection" had passed the Consistency Evaluation of Quality and Efficacy for Generic Drugs. Consequently, Poly Pharma's "Azithromycin for Injection," which was approved in August 2017, is bothFirst ExportDomestic Approval Successfully Obtained for Reformulated Productvarieties, which have now also become part of all injectables approved for market under Category 6 of the former chemical drug registration classificationThe First Officially ApprovedInjectable Products Subject to Consistency Evaluation.
Keywords: Pharmaceuticals
May 28,National Telemedicine CenterIt was officially unveiled at the First Affiliated Hospital of Zhengzhou University. This marks the official upgrade of the “Henan Provincial Telemedicine Center” to a National Telemedicine Center, representing a solid step forward in the national strategy to promote the “Internet + Healthcare” development initiative. It is reported that this is Henan Province’sThe First National-Level Medical Center。
Keywords: Telemedicine, Henan Province
May 28, “Unicorn” in the Medical Device IndustryShenzhen Mindray Bio-Medical Electronics Co., Ltd.Update on the Disclosure of the ChiNext IPO Prospectus. The filing draft shows that Mindray Medical intends to issue no more than 121.6 million RMB ordinary shares (A-shares) to the public, raising RMB 6.34 billion. This marks another push into the A-share market since Mindray Medical voluntarily withdrew its IPO application on February 23.
Keywords: Medical Devices, Unicorn, IPO
May 28,Nanjing Haichen Pharmaceutical Co., Ltd.Announcement on the Proposed Signing of the "Investment Cooperation Agreement for the Haichen Pharmaceutical Production and R&D Base Project" with the People's Government of Feidong County, Anhui ProvinceThe Company proposes to sign the "Investment Cooperation Agreement for the Haichen Pharmaceutical Production and R&D Base Project" with the People's Government of Feidong County, Anhui Province, to invest in and construct a pharmaceutical production and R&D base in the Eastern New City of Feidong County. The project is expected to have a total investment of RMB 400 million.
Keywords: Pharmaceuticals, Investment
May 28,Luye PharmaThe company announced that it has entered into a collaboration agreement with Elpis Biopharmaceuticals Corp., under which both parties will jointly explore and develop dual-target chimeric antigen receptor T-cell (CAR-T) immunotherapy and biological candidate drugs for next-generation cancer immunotherapy.
Keywords: Pharmaceutical, CAR-T
On May 28, China’s globally first-in-class novel biologic drug, Recombinant Cytokine Gene-Derived Protein Injection (brand name: “LeFuneng”), received the Class 1 New Biologic Drug Certificate from the China Food and Drug Administration. This marks the first time in over 30 years thatFirst Occurrence WorldwideThe third class of hepatitis B therapeutic agents will break the ceiling that the seroconversion rate of hepatitis B e antigen cannot exceed 30%.
Keywords: Medicine and Pharmaceuticals
May 28,Tencentaspect announced thatDonghua Software's Holding Company: Donghua ChengxinWith a capital injection of RMB 1.266 billion, it will hold a 5% stake in DHC Software. According to the agreement reached by both parties, Tencent Cloud and DHC Software will focus on deep cooperation in four key areas: medical cloud and healthcare internet applications, smart cities, energy cloud, and financial big data.
Keywords: Healthcare Information Technology
On the evening of May 28,Fosun PharmaThe announcement stated that it had recently received a written resignation letter from Mr. Shao Ying, Vice President, who applied to the Board of Directors to resign from his position as Vice President due to personal reasons. The announcement indicated that Mr. Shao would cease to serve as Vice President of Fosun Pharma effective May 28, 2018, and expressed gratitude for his contributions during his tenure.
Keywords: Pharmaceuticals, Personnel Changes
On the morning of May 29,Alibaba HealthAnnouncement: Officially signed an agreement with Alibaba Group to acquire Tmall’s medical device and healthcare products, adult products, and medical and health services businesses for approximately 1.828 billion shares of Alibaba Health, equivalent to HK$10.6 billion, further integrating its pharmaceutical e-commerce operations.
Keywords: Pharmaceutical E-commerce; Medical Devices
May 30,Yuheng PharmaceuticalThe announcement stated that, following deliberation by the Board of Directors, it was decided to terminate the acquisition of Shanghai Jincheng Information Technology (Group) Co., Ltd., and a “Termination Agreement” was signed through negotiations to recover the RMB 200 million deposit.
Keywords: Pharmaceutical E-commerce; Medical Devices
May 30,Hec TechIn an evening announcement, the company stated that it had received notice on the same day that the Mergers and Acquisitions Restructuring Review Committee of the China Securities Regulatory Commission (CSRC) would review its share issuance for asset acquisition and related-party transactions in the near future. The company’s shares have been suspended from trading since May 31. According to available information, the company had previously suspended trading on March 1 to undergo committee review regarding the acquisition of Dongyangguang Pharmaceutical. The review was later paused due to verification of significant matters involving the company, with a decision on whether to resume the review to be made based on circumstances once the relevant issues are clarified.
Keywords: Mergers and Acquisitions and Restructuring
May 31,National Healthcare Security AdministrationOfficially established, with Hu Jinglin appointed as Director, and Shi Zihai, Chen Jinfu, and Li Tao appointed as Deputy Directors. Its main responsibilities include formulating policies, plans, and standards for medical security systems—such as medical insurance, maternity insurance, and medical assistance—and organizing their implementation; supervising and managing related medical security funds; and improving the national platform for cross-regional medical care management and expense settlement.
Keywords: Policy
Sequoia Capital, Yang Yunxia
In essence, investors focus on three key decisions: choosing the right direction, selecting the right people, and timing the market. If you can master these three aspects, you are ready to engage in investing. However, if your goal is for a project to generate profits and you fail to make the right choices in these areas, you risk losing your entire investment. I believe every investor must be prepared for the possibility of total loss. It is quite fortunate to invest in a unicorn; statistically, the probability of a company becoming a unicorn ranges from 10% to 20%.（Source: VCBeat）
Japanese Team Finds That Comedy Shows Can Boost Human Immunity
On May 29, the Osaka International Cancer Institute in Japan released research findings stating that watching comedy programs—such as rakugo (Japanese solo comic storytelling) and manzai (similar to Chinese crosstalk)—that induce laughter and improve mood can increase the number of immune cells in the human body, thereby benefiting cancer treatment and enhancing patients’ quality of life.(Source: NHK, Japan)
Biosensors Monitor Cell “Communication Behavior” in Real Time
Scientists from Australia’s RMIT University, the École Polytechnique Fédérale de Lausanne (EPFL), and the Ludwig Institute for Cancer Research in Lausanne have developed an integrated optofluidic biosensor capable of isolating individual cells and monitoring their chemical secretions in real time for at least 12 hours. This powerful new tool will provide deeper insights into cellular communication behaviors, paving the way for the development of novel diagnostic and therapeutic approaches for diseases.(Source: www.genengnews.com)
Placental Genes May Induce Schizophrenia in Offspring
According to researchers at the Lieber Institute for Brain Development (LIBD) at Johns Hopkins University School of Medicine, placental genes associated with pregnancy complications may play a key role in triggering schizophrenia in offspring. The researchers stated that their data suggest further studies could identify new strategies for maintaining placental health as a means of preventing schizophrenia, with potentially greater preventive efficacy in males at higher genetic risk.(Source: www.genengnews.com)
AI Voice Recognition Device: A Great Assistant for Doctors in Writing Clinical Records
Health-tech startup Robin Healthcare has launched an AI-powered device with voice recognition capabilities, designed to assist physicians and clinicians in drafting clinical notes. Resembling Amazon’s Alexa or Google’s home voice assistants, the device is placed in doctors’ offices, where it extracts notes from physician-patient conversations, significantly boosting clinical workflow efficiency. (Source: www.mobihealthnews.com)
BGI: “BGI Blockchain White Paper V1.0: Value Exchange of Digital Life”
The white paper summarizes BGI’s understanding of blockchain and its accumulation of related core technologies, shares practical case studies on the application of blockchain and cryptography in scenarios such as life science big data sharing, bio-intelligent computing, and personal health incentives, and puts forward relevant recommendations.
China Galaxy Securities: “A Promising Track in the Healthcare Services Sector – In-Depth Report on the Oncology Healthcare Industry”
This report analyzes the current status and future development trends of both supply and demand in the oncology medical services market, and quantitatively estimates the market size. It examines the profitability and barriers to entry within the oncology medical services industry. Furthermore, it analyzes the key factors contributing to the disparity in five-year cancer survival rates between China and the United States, and draws on the development history of advanced foreign hospitals to identify the critical success factors for private high-end oncology medical service providers.
IQVIA: “Global Oncology Trends 2018”
This report highlights advances in the field of cancer treatment, including the use of these drugs and global consumption trends, innovative therapeutic pipelines and related clinical trial activities, as well as the outlook for 2022.
For more information, please refer to the VCBeat knowledge base!
